scispace - formally typeset
S

Satoru Miyano

Researcher at Tokyo Medical and Dental University

Publications -  874
Citations -  45801

Satoru Miyano is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Gene & Gene regulatory network. The author has an hindex of 84, co-authored 811 publications receiving 38723 citations. Previous affiliations of Satoru Miyano include University of Paderborn & Institute of Medical Science.

Papers
More filters
Journal ArticleDOI

Spliceosomal Gene LUC7L2 Mutation Causes Missplicing and Alteration Of Gene Expression In Myeloid Neoplasms

TL;DR: This project focused its study on the LUC7L2 gene encoding a spliceosomal protein that interacts with U1 snRNP to recognize 5’ splice sites, in contrast to other splICEosomal genes mutated in MDS, which found abnormal splicing of genes involved in functionally important pathways including the RAS pathway (NF1) and the TGF-β pathway (SMAD5).
Book ChapterDOI

Starting Cell Illustrator

TL;DR: This chapter uses Cell Illustrator 3.0 (CI3.0) to understand the procedures for creating and simulating pathway models and shows how to model and simulate by drawing a pathway.
Proceedings ArticleDOI

Revolutionizing Cancer Genomic Medicine by AI and Supercomputer with Big Data

TL;DR: How the system works as a conglomerate of oncologists, cancer biologists, bioinformatics experts augmented with Watson and Genomon is reported, which drastically resolved the bottleneck of interpretation/translation.
Book ChapterDOI

Gene Networks: Estimation, Modeling, and Simulation

TL;DR: This chapter describes the computational methods for estimating, modeling, and simulating biological systems, and devised a method to infer a gene network in terms of a linear system of differential equations from time-course gene expression data.
Journal ArticleDOI

Uncovering Molecular Mechanisms of Drug Resistance via Network-Constrained Common Structure Identification

TL;DR: A novel computational method is proposed, designated network-constrained sparse common component analysis (NetSCCA), that extracts common structures of multiple networks characterizing molecular interaction in drug-sensitive and drug-resistant cell lines and has the capacity to characterize the molecular interplay between genes and crucial markers related to mechanisms of acquired drug resistance that cannot be revealed by analysis based solely on DEG.